1. Breese GR, AA Baumeister, TJ McCown, SG Emerick, GD Frye, K Crotty and RA Mueller (1984) Behavioural differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.J. Pharmacol. Exp. Ther. 231, 343–354.
2. Breese GR, AA Baumeister, TC Napier, GD Frye and RA Mueller (1985a) Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydrox-yphenylalanine in rats treated neonatally with 6-hydroxy-dopamine.J. Pharmacol. Exp. Ther. 235, 287–295.
3. Breese GR, TC Napier and RA Mueller (1985b) Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxy-dopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally-lesioned rats.J. Pharmacol. Exp. Ther. 234, 447–455.
4. Breese GR, GE Duncan, TC Napier, SC Bondy, LC Iorio and RA Mueller (1987) 6-Hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D(1)- and D(2)-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.J. Pharmacol. Exp. Ther. 240, 167–176.
5. Brown RW, JT Gass and RM Kostrzewa (2002) Ontogenetic quin-pirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats.Pharmacol. Biochem. Behav. 72, 591–600.